In the BioHarmony Drug Report Database
Tipiracil
Lonsurf (tipiracil) is a small molecule pharmaceutical. Tipiracil was first approved as Lonsurf on 2015-09-22. It is used to treat colorectal neoplasms in the USA. It has been approved in Europe to treat colorectal neoplasms. Lonsurf’s patents are valid until 2037-02-03 (FDA).
Trade Name
|
Lonsurf |
|---|---|
Common Name
|
tipiracil |
ChEMBL ID
|
CHEMBL235668 |
Indication
|
colorectal neoplasms |
Drug Class
|
Uracil type antineoplastics |
Image (chem structure or protein)